RS, first described by Rowell et al. in 1963, refers to the coexistence of lupus erythematosus and erythema multiforme (EM)-like lesions with immunological features such as positive ANA and anti-Ro/La antibodies [6,7]. This evidence concerns the gene BTG3 and lupus erythematosus.